This groundbreaking Bachelor-Master program unites passions for discovery research and the desire to understand its role in commerce.
Combines specializations for
Opens doors to
Diverse Employment Opportunities
Competitive Edge in the Biomedical Field
WE ENVISION A NEW GENRE OF BIOMEDICAL SCIENTISTS
WHO WILL LEAD IN BOTH DISCOVERY AND COMMERCE
From the Director
It’s my pleasure to welcome you to the new Biomedical Discovery and Commercialization (BDC) program. The program is the culmination of much planning for a multidisciplinary training program, concentrated in the biomedical sciences which equips graduates with strong discovery research skills, business acumen and a meaningful experiential connection to the Health Sciences sector. This innovative ‘4+1’ year Bachelor – Master program provides a unique entry point – level III of undergraduate studies – for students in the Health, Life, and Physical Sciences. Students in other programs may also be eligible to apply, depending on their educational background.
Our goal is to position graduates for advanced training in the biomedical sciences and to become leaders in the health sciences, drug discovery and development sectors. Throughout its development we have been witness to tremendous interest in the new program from both students and industry. Accordingly, due to strong demand we implemented the BDC program with an ambitious and accelerated timetable.
In January 2015 we implemented an accelerated launch of the program with a small cohort, who completed an abbreviated third-year curriculum. These students are currently completing their Master’s of Biomedical Discovery and Commercialization degree, and began their Community Internships in January of 2017. I look forward to seeing the first Master’s class of 2017, graduate this summer.
September 2015 marked an exciting time for the program as we welcomed our first full level III cohort. These third-year BDC students transferred from a diverse range of programs (e.g., Biochemistry, Biology, Chemistry, Life Science), which makes for an enriched classroom environment where students discuss problems from different perspectives.
It’s an exciting time for the BDC program and I look forward to the journey ahead and seeing our students become leaders in their chosen field.
Eric Brown, Program Director, Professor
Department of Biochemistry and Biomedical Sciences
The Biomedical Discovery and Commercialization (BDC) program is a new, limited enrollment offering by the Department of Biochemistry and Biomedical Sciences with key contributions from the School of Business. The training program will encompass level III and IV of undergraduate studies as well as a 12-month course-based Master program. The latter will include an internship in the health sciences sector.
This limited enrollment program will afford a unique educational experience for students seeking first-rate training in the biomedical sciences with an emphasis on drug discovery and development. Advanced training in biomedical discovery will come from accomplished research faculty who will provide individual mentorship in cutting-edge research investigations, and award-winning professors in the School of Business will instruct students in the fundamentals of commerce. At the nexus of science and business, the program will reach out in an extraordinary way to the commercial health sciences sector for its participation, both as guest lecturers in the classroom and as mentors in the community.
In all, innovative educational methods using experiential, inquiry and team based learning approaches will be a hallmark for this exciting new program. Thus, students will benefit from a vanguard, multi-disciplinary educational experience aimed at positioning graduates for career success in the health sciences sector.
WHAT ARE STUDENTS AND
INDUSTRY PROFESSIONALS SAYING ABOUT THE BDC PROGRAM?
See what people are people saying about BDC in our 2016 video
INDUSTRY PROFESSIONALS ARE EAGER TO CONTRIBUTE TO THE PROGRAM
What are people saying about BDC?
At Biogen Idec we’re very enthusiastic about McMaster’s new program in Biomedical Discovery and Commercialization. It’s a privilege frankly to contribute as community mentors because we are supportive of drug discovery and passionate about developing future scientists, with the goal of improving patient outcomes with rare diseases. We see this as an exciting opportunity to help in the learning process.
We’re very excited about the opportunity to work with McMaster’s new Biomedical Discovery and Commercialization program. The team members at Bloom Burton & Co. have deep knowledge across many areas such as science, commercialization, business, investments and drug development. We see BDC students as future colleagues, and are enthusiastic to participate as mentors.